TSW
GMED icon

Thompson Siegel & Walmsley’s Globus Medical GMED Stock Holding History

Thompson Siegel & Walmsley’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-85,550
Closed -$4.9M – 412
2025
Q3 		$4.9M Buy
+85,550
New +$4.93M 0.08% 224
2017
Q1 		– Sell
-75
Closed -$2K – 892
2016
Q4 		$2K Buy
+75
New +$1.7K ﹤0.01% 771

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Thompson Siegel & Walmsley's GMED Position: Q4 2025 in Review

Thompson Siegel & Walmsley sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 85,550 shares — an estimated $4.9M sold.

Thompson Siegel & Walmsley first reported a position in GMED in Q4 2016 and held it in 2 quarters. The position peaked at $4.9M in Q3 2025. 563 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • Thompson Siegel & Walmsley reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 85,550 Globus Medical shares in Q4 2025, an estimated $4.9M.
  • Thompson Siegel & Walmsley first reported a position in Globus Medical in Q4 2016 and held it in 2 quarters.
  • Thompson Siegel & Walmsley's Globus Medical position peaked at $4.9M in Q3 2025.
  • 563 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Thompson Siegel & Walmsley's 13F filing for Q4 2025, filed 10 Feb 2026.